Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial
暂无分享，去创建一个
T. Brümmendorf | R. Clark | M. Deininger | C. Chuah | J. Lipton | M. Mauro | P. Rousselot | E. Leip | D. Milojković | C. Gambacorti-Passerini | A. Hochhaus | S. Purcell | P. le Coutre | V. García-Gutiérrez | V. Kota | Jordi Cortés | A. Yver | A. Viqueira | R. Hurtado Monroy | V. García‐Gutiérrez | D. Milojkovic